Your browser doesn't support javascript.
loading
Alternating high-fat diet enhances atherosclerosis by neutrophil reprogramming.
Lavillegrand, Jean-Rémi; Al-Rifai, Rida; Thietart, Sara; Guyon, Théo; Vandestienne, Marie; Cohen, Raphael; Duval, Vincent; Zhong, Xiaodan; Yen, Daniel; Ozturk, Mumin; Negishi, Yutaka; Konkel, Joanne; Pinteaux, Emmanuel; Lenoir, Olivia; Vilar, Jose; Laurans, Ludivine; Esposito, Bruno; Bredon, Marius; Sokol, Harry; Diedisheim, Marc; Saliba, Antoine-Emmanuel; Zernecke, Alma; Cochain, Clément; Haub, Jessica; Tedgui, Alain; Speck, Nancy A; Taleb, Soraya; Mhlanga, Musa M; Schlitzer, Andreas; Riksen, Niels P; Ait-Oufella, Hafid.
Afiliación
  • Lavillegrand JR; Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France.
  • Al-Rifai R; Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France.
  • Thietart S; Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France.
  • Guyon T; Geriatrics Department, Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié Salpêtrière, Paris, France.
  • Vandestienne M; Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France.
  • Cohen R; Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France.
  • Duval V; Quantitative Systems Biology, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Zhong X; Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France.
  • Yen D; Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France.
  • Ozturk M; Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France.
  • Negishi Y; Department of Cell and Developmental Biology and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Konkel J; Department of Cell Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University FNWI, Nijmegen, The Netherlands.
  • Pinteaux E; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Lenoir O; Department of Cell Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University FNWI, Nijmegen, The Netherlands.
  • Vilar J; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Laurans L; Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Esposito B; Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
  • Bredon M; Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France.
  • Sokol H; Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France.
  • Diedisheim M; Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France.
  • Saliba AE; Paris Cardiovascular Research Center, Université Paris Cité, INSERM U970, Paris, France.
  • Zernecke A; Gastroenterology Department, Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Saint Antoine Hospital, Paris, France.
  • Cochain C; Paris Center for Microbiome Medicine (PaCeMM) FHU, Paris, France.
  • Haub J; Gastroenterology Department, Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Saint Antoine Hospital, Paris, France.
  • Tedgui A; Paris Center for Microbiome Medicine (PaCeMM) FHU, Paris, France.
  • Speck NA; INRAE, AgroParisTech, Micalis Institute, Jouy-en-Josas, France.
  • Taleb S; Clinique Saint Gatien Alliance (NCT+), Saint-Cyr-sur-Loire, France.
  • Mhlanga MM; IMMEDIAB Laboratory, INSERM U1151, Necker Enfants Malades (INEM), Paris, France.
  • Schlitzer A; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center for Infection Research (HZI), Würzburg, Germany.
  • Riksen NP; Institute of Experimental Biomedicine, University Hospital Wuerzburg, Würzburg, Germany.
  • Ait-Oufella H; Institute of Experimental Biomedicine, University Hospital Wuerzburg, Würzburg, Germany.
Nature ; 634(8033): 447-456, 2024 Oct.
Article en En | MEDLINE | ID: mdl-39232165
ABSTRACT
Systemic immune responses caused by chronic hypercholesterolaemia contribute to atherosclerosis initiation, progression and complications1. However, individuals often change their dietary habits over time2, and the effects of an alternating high-fat diet (HFD) on atherosclerosis remain unclear. Here, to address this relevant issue, we developed a protocol using atherosclerosis-prone mice to compare an alternating versus continuous HFD while maintaining similar overall exposure periods. We found that an alternating HFD accelerated atherosclerosis in Ldlr-/- and Apoe-/- mice compared with a continuous HFD. This pro-atherogenic effect of the alternating HFD was also observed in Apoe-/-Rag2-/- mice lacking T, B and natural killer T cells, ruling out the role of the adaptive immune system in the observed phenotype. Discontinuing the HFD in the alternating HFD group downregulated RUNX13, promoting inflammatory signalling in bone marrow myeloid progenitors. After re-exposure to an HFD, these cells produced IL-1ß, leading to emergency myelopoiesis and increased neutrophil levels in blood. Neutrophils infiltrated plaques and released neutrophil extracellular traps, exacerbating atherosclerosis. Specific depletion of neutrophils or inhibition of IL-1ß pathways abolished emergency myelopoiesis and reversed the pro-atherogenic effects of the alternating HFD. This study highlights the role of IL-1ß-dependent neutrophil progenitor reprogramming in accelerated atherosclerosis induced by alternating HFD.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Apolipoproteínas E / Receptores de LDL / Mielopoyesis / Aterosclerosis / Interleucina-1beta / Reprogramación Celular / Dieta Alta en Grasa / Neutrófilos Límite: Animals Idioma: En Revista: Nature / Nature (Lond.) / Nature (London) Año: 2024 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Apolipoproteínas E / Receptores de LDL / Mielopoyesis / Aterosclerosis / Interleucina-1beta / Reprogramación Celular / Dieta Alta en Grasa / Neutrófilos Límite: Animals Idioma: En Revista: Nature / Nature (Lond.) / Nature (London) Año: 2024 Tipo del documento: Article País de afiliación: Francia